BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10775583)

  • 1. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity.
    Pietschmann T; Zentgraf H; Rethwilm A; Lindemann D
    J Virol; 2000 May; 74(10):4474-82. PubMed ID: 10775583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal Gag domain required for foamy virus particle assembly and export.
    Cartellieri M; Herchenröder O; Rudolph W; Heinkelein M; Lindemann D; Zentgraf H; Rethwilm A
    J Virol; 2005 Oct; 79(19):12464-76. PubMed ID: 16160174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly.
    Eastman SW; Linial ML
    J Virol; 2001 Aug; 75(15):6857-64. PubMed ID: 11435565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential pH-dependent cellular uptake pathways among foamy viruses elucidated using dual-colored fluorescent particles.
    Stirnnagel K; Schupp D; Dupont A; Kudryavtsev V; Reh J; Müllers E; Lamb DC; Lindemann D
    Retrovirology; 2012 Aug; 9():71. PubMed ID: 22935135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process.
    Picard-Maureau M; Jarmy G; Berg A; Rethwilm A; Lindemann D
    J Virol; 2003 Apr; 77(8):4722-30. PubMed ID: 12663779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foamy virus capsids require the cognate envelope protein for particle export.
    Pietschmann T; Heinkelein M; Heldmann M; Zentgraf H; Rethwilm A; Lindemann D
    J Virol; 1999 Apr; 73(4):2613-21. PubMed ID: 10074106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of transmembrane subunits gp47 of the foamy virus envelope glycoproteins.
    Wang M; Zhang H; Liu QM; Sun Y; Li Z; Liu WH; He XH; Song J; Wang YX
    Acta Virol; 2016 Jun; 60(2):181-9. PubMed ID: 27265468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foamy virus envelope glycoprotein is sufficient for particle budding and release.
    Shaw KL; Lindemann D; Mulligan MJ; Goepfert PA
    J Virol; 2003 Feb; 77(4):2338-48. PubMed ID: 12551971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An N-terminal domain helical motif of Prototype Foamy Virus Gag with dual functions essential for particle egress and viral infectivity.
    Reh J; Stange A; Götz A; Rönitz M; Große A; Lindemann D
    Retrovirology; 2013 Apr; 10():45. PubMed ID: 23618494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the R572T point mutant of a putative cleavage site in human foamy virus Env.
    Bansal A; Shaw KL; Edwards BH; Goepfert PA; Mulligan MJ
    J Virol; 2000 Mar; 74(6):2949-54. PubMed ID: 10684317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenesis of N-terminal residues of feline foamy virus Gag reveals entirely distinct functions during capsid formation, particle assembly, Gag processing and budding.
    Liu Y; Betts MJ; Lei J; Wei G; Bao Q; Kehl T; Russell RB; Löchelt M
    Retrovirology; 2016 Aug; 13(1):57. PubMed ID: 27549192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and manipulation of foamy virus membrane interactions.
    Swiersy A; Wiek C; Zentgraf H; Lindemann D
    Cell Microbiol; 2013 Feb; 15(2):227-36. PubMed ID: 23051660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The foamy virus envelope glycoproteins.
    Lindemann D; Goepfert PA
    Curr Top Microbiol Immunol; 2003; 277():111-29. PubMed ID: 12908770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle.
    Enssle J; Fischer N; Moebes A; Mauer B; Smola U; Rethwilm A
    J Virol; 1997 Oct; 71(10):7312-7. PubMed ID: 9311808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity.
    Lindemann D; Pietschmann T; Picard-Maureau M; Berg A; Heinkelein M; Thurow J; Knaus P; Zentgraf H; Rethwilm A
    J Virol; 2001 Jul; 75(13):5762-71. PubMed ID: 11390578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions.
    Celma CC; Paladino MG; González SA; Affranchino JL
    Virology; 2007 Sep; 366(2):405-14. PubMed ID: 17559903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release.
    Stanke N; Stange A; Lüftenegger D; Zentgraf H; Lindemann D
    J Virol; 2005 Dec; 79(24):15074-83. PubMed ID: 16306578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity.
    Duda A; Stange A; Lüftenegger D; Stanke N; Westphal D; Pietschmann T; Eastman SW; Linial ML; Rethwilm A; Lindemann D
    J Virol; 2004 Dec; 78(24):13865-70. PubMed ID: 15564494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthoretroviral-like prototype foamy virus Gag-Pol expression is compatible with viral replication.
    Swiersy A; Wiek C; Reh J; Zentgraf H; Lindemann D
    Retrovirology; 2011 Aug; 8():66. PubMed ID: 21843316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL; González SA
    Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.